LUNA 3: Rilzabrutinib in ITP
LUNA 3: Phase III Trial of Rilzabrutinib vs Placebo in Patients Aged ≥18 Yr With Persistent/Chronic Primary ITP

Released: December 11, 2024

Expiration: December 10, 2025

Activity

Progress
1
Course Completed